NHS: Drugs

Health written question – answered on 15th October 2008.

Alert me about debates like this

Photo of Tom Brake Tom Brake Shadow Minister (Olympics and London), Shadow Minister (Home Affairs), Liberal Democrat Spokesperson (Home Affairs), Liberal Democrat Spokesperson (Olympics and London)

To ask the Secretary of State for Health under what circumstances an exceptional uses medical panel may reverse a clinician's recommendation for treatment with a drug approved by the National Institute for Health and Clinical Excellence; and if he will make a statement.

Photo of Dawn Primarolo Dawn Primarolo Minister of State (Department of Health) (Public Health)

Unless it has been amended or waived for a specific treatment, a statutory funding direction requires national health service organisations to make funding available for treatments recommended by the National Institute for Health and Clinical Excellence (NICE) within three months of publication of final guidance. The Government would not expect a primary care trust to refuse funding for a treatment prescribed by the patient's clinician that has been recommended by NICE and is covered by the funding direction.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.